This is an old revision of the document!

COVID-19 Therapeutics Task Force

The COVID-19 Therapeutics Task Force was a Canadian public-private advisory body convened by Innovation, Science and Economic Development Canada (ISED).¹⁾

Members

Members
Name	Position	Affiliation(s)
Nancy Harrison	Co-chair	Life Sciences British Columbia, Ventures West, MSI Methylation Sciences, Creative Destruction Lab, adMare BioInnovations, Digital Technology Supercluster, Genome British Columbia, Knight Therapeutics
Cédric Bisson	Co-chair	Teralys Capital, iNovia Capital, McKinsey & Company, Montreal InVivo, Grand Challenges Canada, Procure
Maha Katabi	Member	Sofinnova, Amplyx Pharmaceuticals, Northsea Therapeutics, Oxalis Capital, Sectoral Asset Management, Ventures West Management, T2C2 Capital, Exactis Innovation
Gordon McCauley	Member	adMare BioInnovations, Viable Healthworks, Allon Therapeutics, NDI Cpaital, BIOTECanada, CGen, Life Sciences British Columbia, Biotechnology Innovation Organization (BIO), Acetech, Toronto Rehabilitation Institute, Toronto Rehab Foundation
Parimal Nathwani	Member	Toronto Innovation Acceleration Partners (TIAP), MaRS Discovery District, UBC University Industry Liaison Office (UILO), TRIUMF Innovations, Zucara Therapeutics, Vasomune Therapeutics, Encycle Therapeutics

¹⁾